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ABSTRACT
Staphylococcus pseudintermedius is part of the normal fl ora of dogs but is also commonly found as an 
opportunistic pathogen. Antimicrobial resistance in S. pseudintermedius is changing over time and is generally 
rising steadily for those antimicrobials that are frequently used. In this work, the susceptibility of 106 canine and 
feline isolates of S. pseudintermedius was determined by the disk-diffusion method. Isolates were collected from 
various body sites of diseased dogs and cats during a six-month period in 2011. Most isolates were susceptible 
to amoxycillin/clavulanic acid, cephalexin, enrofl oxacin and oxacillin (92.5%), followed by trimethoprim-
sulfamethoxazole (90.6%) and gentamicin (82.1%). Lower susceptibility was found for minocycline (67.0%), 
erythromycin, clindamycin and tetracycline (62.3%) and kanamycin (58.5%). Only 21.7% of the isolates 
were susceptible to ampicillin. Susceptibilities of isolates were compared from different isolation sites and 
from different temporal origins. The possible association of resistances to different antimicrobial agents is 
discussed.
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Introduction
Staphylococcus pseudintermedius belongs to the Staphylococcus intermedius 
group  (SIG) together with the closely related species Staphylococcus intermedius 
and Staphylococcus delphini (BANNOEHR et al., 2007). It is one of the most common 
pathogens isolated from skin and ear infections in dogs (PETERSEN et al., 2002). This 
bacterial species commonly occurs as part of the normal fl ora of dogs, but can also be 
an opportunistic pathogen. Antimicrobial resistance in S. pseudintermedius is changing 
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over time and is generally rising steadily for those antimicrobials that are frequently used 
(AUTHIER et al., 2006; ONUMA et al., 2012).
The susceptibility of SIG isolated from dogs and cats in Croatia was investigated 15 
years ago and showed rather low resistance rates except for ampicillin, macrolides and 
chloramphenicol (NAGLIĆ et al., 1998). The investigation of susceptibility to cefovecin 
in Croatia showed that this third-generation cephalosporin was active against 92.8% 
S. pseudintermedius isolates (ŠEOL et al., 2011). In 2009, we reported the emergence 
of methicillin-resistant S. pseudintermedius (MRSP) in Croatia and determined its 
susceptibility to antimicrobials (MATANOVIĆ et al., 2009).
The aim of the present study was to examine the occurrence of antimicrobial resistance 
in S. pseudintermedius isolated from diseased dogs and cats in Croatia.
Materials and methods
During a six-month period, from April to September 2011, specimens originating from 
diseased cats and dogs were submitted for microbiological examination to the bacteriology 
laboratory at the Department for Microbiology and Infectious Diseases with Clinic of the 
Faculty of Veterinary Medicine, University of Zagreb. The majority of samples were 
collected from animals examined at the Clinics of the Faculty of Veterinary Medicine, 
University of Zagreb, while a smaller portion originated from private veterinary clinics 
throughout Croatia. History on previous antimicrobial chemotherapy was not available. 
Samples were streaked on Columbia agar with 5% sheep blood (Bio-Rad, France) and 
incubated at 37 ºC for 18 h. Isolates were identifi ed as members of the SIG on the basis 
of beta-hemolysin production and biochemical properties as described by SASAKI et al. 
(2007), and were stored at -20 ºC until further analysis. Replicate isolates from the same 
animal were excluded. DNA was isolated from overnight cultures grown on Columbia 
agar (Bio-Rad, France). Briefl y, several bacterial colonies were picked from agar and 
suspended in 200 μl of 2% Chelex-100 solution (Bio-Rad, USA). After thermal lysis 
at 100 ºC for 10 min suspensions were chilled on ice, centrifuged at 13000×g for 10 
min, and supernatant was used as DNA template. Identifi cation of S. pseudintermedius 
to the species level and detection of mecA gene were performed by polymerase chain 
reaction, using a Promega Core System I (Promega, USA) kit and the primers previously 
described (ZUBEIR et al., 2007; SASAKI et al., 2010). Only isolates that were confi rmed as 
S. pseudintermedius were included in susceptibility testing. 
Susceptibility to antimicrobials was determined on Mueller-Hinton agar (Bio-Rad, 
France) using the disk-diffusion procedure according to recommendations by the Clinical 
and Laboratory Standards Institute (ANONYMOUS, 2008). The following antimicrobial 
disks (Bio-Rad, USA) were used: amoxycillin/clavulanic acid (20/10 μg), ampicillin (10 
μg), chloramphenicol (30 μg), clindamycin (2 μg), enrofl oxacin (5 μg), erythromycin 
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(15 μg), gentamicin (10 μg), kanamycin (30 μg), minocycline (30 μg), tetracycline (30 
μg) and trimethoprim-sulfamethoxazole (1.25/23.75 μg). Cephalotin (30 μg) was used to 
predict the susceptibility to cephalexin (ANONYMOUS, 2008). Inhibition zone diameters 
were interpreted according to criteria recommended in CLSI documents M31-A3 and, 
for kanamycin and minocycline, M100-S20 (ANONYMOUS, 2008; ANONYMOUS, 
2010). S. aureus ATCC 25923 was used as a control strain. Susceptibility to oxacillin 
was determined on Mueller-Hinton agar (Bio-Rad, France) supplemented with 2% 
NaCl using 1 μg oxacillin disks (Bio-Rad, USA), and zone diameters were interpreted 
as recommended by the CLSI subcommittee on Veterinary Antimicrobial Susceptibility 
Testing (PAPICH, 2010). Inducible clindamycin resistance was tested using the D-test 
(ANONYMOUS, 2010).
Statistical analysis was performed using Statistica (Statsoft, USA) and MedCalc 
(MedCalc Software, Belgium) software. The proportions of susceptible and resistant 
categories between isolates obtained from the skin and ear canal were compared by 
Chi-square test. Association of resistances between different antimicrobial agents was 
examined by Cochran’s Q test. Statistical signifi cance was set at P<0.05. For statistical 
analysis all intermediate sensitive isolates were included in the resistant category.
Results
In this work 106 isolates of S. pseudintermedius were isolated from 102 dogs and 
four cats. All isolates were associated with clinical disease and were recovered from the 
affected sites: skin (40), external ear canal (39), conjunctival sac (8), nostrils (7), infected 
wounds (6), urine (4) and the female genital tract (2).
A 960 bp DNA fragment of the nuc gene was amplifi ed by PCR in all S. 
pseudintermedius isolates (Fig. 1).
The results of susceptibility testing are presented in Table 1. In this study 8 (7.5%) 
isolates of S. pseudintermedius were resistant to oxacillin. MRSP was isolated from the 
skin (2), ear canal (2), infected wounds (2) and urine (1) of dogs and from a nostril (1) 
of a cat. All isolates resistant to oxacillin carried the mecA gene, and were also resistant 
to amoxycillin/clavulanic acid and cephalexin. All oxacillin-sensitive isolates were 
susceptible to amoxycillin/clavulanic acid and cephalexin. Out of 40 isolates resistant to 
erythromycin, 32 were also resistant to clindamycin. The remaining eight erythromycin-
resistant isolates, which were intermediate susceptible (six isolates) or resistant (two 
isolates) to clindamycin in disk-diffusion testing, were positive in the D-test and classifi ed 
as inducible resistant to clindamycin. When these data are taken together, all 40 (37.7%) 
isolates resistant to erythromycin were also resistant to clindamycin. No isolates were 
susceptible to clindamycin and positive in the D-test.
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Table 2. Antimicrobial resistance patterns detected among 106 isolates of Staphylococcus 
pseudintermedius
Antimicrobial agents No. of isolates
No resistance 23
AM 30
AM + GM + K 1
AM + MNO + TE 8
AM + MNO + SXT + TE 1
AM + GM + K + TE 1
AM + K + MNO + TE 1
AM + GM + K + MNO + TE 1
AM + C + CM + E + K 5
AM + C + CM + E + GM + K 2
AM + C + CM + E + K + TE 3
AM + CM + E + K + MNO + TE 5
AM + C + CM + E + K + MNO + TE 7
AM + CM + E + GM + K + MNO + TE 1
AM + CM + E + K + MNO + SXT + TE 1
AM + C + CM + E + GM + K + MNO + TE 7
AM + C + CM + E + ENR + K + MNO + TE 1
AM + AMC + CM + CN + E + ENR + GM + K + OX + SXT 3
AM + AMC + CM + CN + E + K + MNO + OX + SXT + TE 1
AM + AMC + C + CM + CN + E + ENR + GM + K + OX + SXT 3
AM + AMC + CM + CN + E + ENR + K + MNO + OX + SXT + TE 1
Total 106
AM  = ampicillin; AMC = amoxycillin/clavulanic acid; C = chloramphenicol; CM = clindamycin; CN = 
cephalexin; E = erythromycin; ENR = enrofl oxacin; GM = gentamicin; K = kanamycin; MNO = minocycline; 
OX = oxacillin; SXT = sulfamethoxazole/trimethoprim; TE = tetracycline.
Fig. 1. Agarose gel-electrophoresis showing 960 bp fragment of the nuc gene for 16 representative 
S. pseudintermedius isolates. M = Promega BenchTop 100bp DNA Ladder (Promega, USA); 
Lanes 1-16 = S. pseudintermedius isolates; Lane 17 = negative control; Lane 18 = positive control 
(methicillin-resistant S. pseudintermedius ST71-t02).
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There was no statistically signifi cant difference in susceptibility to antimicrobials 
between isolates obtained from the skin and external ear canal (Chi-square test, P>0.05). 
Cochran’s Q test revealed a statistically signifi cant association between resistance 
to erythromycin, kanamycin, gentamicin and chloramphenicol (P<0.05). Resistance 
to tetracycline was associated with resistance to erythromycin, kanamycin and 
chloramphenicol (Cochran’s Q test, P<0.05) but not with gentamicin and ampicillin. 
Table 2 shows the different resistance patterns based on the number of antimicrobials 
to which the isolates were resistant. Only 23 (21.7%) isolates were susceptible to all 
antimicrobial agents tested. All isolates resistant to at least three antimicrobials were 
always resistant to ampicillin, i.e. resistance to any antimicrobial was always associated 
with resistance to ampicillin. There was a high proportion (37.7%) of multiresistant isolates 
(resistant to four or more classes of antimicrobials). Among them, the two most common 
patterns included resistance to ampicillin, macrolides, lincosamides, aminoglycosides, 
tetracyclines and chloramphenicol.
Discussion
Resistance to beta-lactamase sensitive penicillins is widespread among staphylococci 
of human and animal origin. The resistance rate of 78.3% for ampicillin determined in 
this study is similar to that found in SIG isolates from fi rst-time and recurrent cases of 
pyoderma in dogs in Sweden (HOLM et al., 2002) and diseased cats and dogs in Switzerland 
(BOERLIN et al., 2001). Other studies conducted on diseased dogs (FUTAGAWA-SAITO et 
al., 2007; PENNA et al., 2010) detected lower resistant rates. Differences in locality and 
investigation period might be among the possible reasons for the variations in the reported 
resistance rates. Our fi ndings show that beta-lactamase sensitive penicillins can no longer 
be used for treatment of canine staphylococcal infections in Croatia due to the very high 
number of resistant isolates. 
The emergence of MRSP poses signifi cant problems to veterinarians treating infected 
animals. The fi rst isolates of MRSP in Croatia were detected in 2008 (MATANOVIĆ et 
al., 2009). Two studies conducted in Italy, the closest country to Croatia with reports on 
MRSP, reported half the oxacillin resistance rate in S. pseudintermedius than found in 
this work (VANNI et al., 2009; MEUCCI et al., 2010). However, in another Italian study, 
21% MRSP was found among canine isolates from the Staphylococcus intermedius group 
(DE LUCIA et al., 2011). Nevertheless, our data is similar to the 7.4% MRSP prevalence 
detected among SIG isolates from canine diagnostic samples in Germany (RUSCHER 
et al., 2009). According to a CLSI document M100-S20 (ANONYMOUS, 2010), isolates 
susceptible to oxacillin can be considered susceptible to penicillinase-stable penicillins, 
such as amoxicillin/clavulanic acid, and cephalosporins, such as cephalexin, the two most 
commonly used beta-lactams in dogs. This was also confi rmed in our study.
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In this work, 37.7% of isolates were simultaneously resistant to erythromycin and 
clindamycin (inducible-resistant isolates included). This fi nding is quite surprising if 
we bear in mind that these antimicrobials are not commonly used in dogs and cats in 
Croatia. In addition, the percentage of erythromycin-resistant isolates in this study is 
almost identical to that reported by NAGLIĆ et al. (1998) in Croatia 15 years ago, where 
of 36 SIG isolates examined 38.9% were resistant to erythromycin. In a similar study 
conducted in Canada, only 5% and 4% of S. pseudintermedius isolates from canine otitis 
externa were resistant to erythromycin and clindamycin, respectively (HARIHARAN et al., 
2006). Lower resistance rates for these antimicrobials were also reported for isolates from 
diseased dogs in the USA (HARTMANN et al., 2005), Denmark (PEDERSEN et al., 2007) and 
France (GANIERE et al., 2005) but in these studies susceptibility testing was performed by 
the broth microdilution method rather than disk-diffusion. The relatively high resistance 
rate determined in this work may be a result of co-selection of erythromycin resistance 
during therapy with other antimicrobials (BOERLIN et al., 2001). In the latter study the 
authors found that the ermB gene, conferring resistance to macrolides, lincosamides 
and streptogramin B, is physically linked to the aadE-sat4-aphA-3 gene cluster in SIG 
isolates from dogs and cats. This cluster confers resistance to kanamycin, neomycin, 
streptothricin and streptomycin so therapy with any of these antimicrobials, such 
as neomycin, included in many topical formulations, will also select for resistance to 
macrolides and lincosamides. 
The prevalence of resistance to tetracycline in our study was 37.7%, which is similar 
or lower to that determined by the broth microdilution method for canine clinical isolates 
in France (GANIERE et al., 2005), USA (HARTMANN et al., 2005), Norway (NORSTRÖM 
et al., 2009) and Japan (ONUMA et al., 2012), but higher than that found in isolates from 
diseased dogs in Denmark (PEDERSEN et al., 2007). In addition, the prevalence of 
resistance to tetracycline in our study was the same as erythromycin resistance, which 
is quite surprising considering the rare use of tetracycline in dogs and cats (ESCHER et 
al., 2011; MATEUS et al., 2011). It has been suggested that tetracycline-resistant isolates 
may be co-selected by therapy with other antimicrobial agents and so further increase the 
overall level of resistance to tetracycline (HOLM et al., 2002).
Of the 40 tetracycline-resistant isolates, 35 (87.5%) were also minocycline-resistant 
(intermediate isolates included in the resistant category). This phenotype is usually 
associated with the presence of the tetM gene, encoded on the transposon, which confers 
resistance to tetracycline and minocycline via the ribosomal protection mechanism. Five 
out of 40 (12.5%) tetracycline-resistant isolates were susceptible to minocycline. These 
isolates probably carry a tetK gene, previously found on plasmids, and encoding effl ux 
pump-mediated resistance (SCHWARZ et al., 1998).
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Although gentamicin showed the highest activity among the tested aminoglycosides, 
almost 18% of isolates were resistant to this agent. This is in contrast to other studies, 
where the gentamicin resistance rate was signifi cantly lower, and ranged from 0% to 9.1% 
(GANIERE et al., 2005; HARTMANN et al., 2005; HARIHARAN et al., 2006; FUTAGAWA-
SAITO et al., 2007; NORSTRÖM et al., 2009; VANNI et al., 2009). However, in those studies the 
prevalence of MRSP was low, while in this study gentamicin-resistant MRSP signifi cantly 
contributed to the observed gentamicin resistance rate. Even though gentamicin is not a 
common choice for systemic therapy in dogs and cats, it is often used in Croatia for the 
topical treatment of localized skin infections, otitis externa and conjunctivitis. This may 
explain the relatively high resistance level to this antibiotic. However, a signifi cantly 
lower resistance level was found in the study conducted by NAGLIĆ et al. (1998) in Croatia, 
where only one out of 180 (0.6%) SIG isolates was resistant to this agent. This increase is 
alarming and might lead to the ineffectiveness of this important antibiotic in the future.  
Although chloramphenicol use is banned in food producing animals, it is still used 
in Croatia for topical treatment in pets. This might be the reason why more than a quarter 
of isolates was resistant to this antibiotic. Interestingly, 33 out of 46 (28.3%) SIG isolates 
from dogs were found to be resistant to chloramphenicol in a previous study (NAGLIĆ 
et al., 1998), so it seems that the resistance to this drug has remained stable in Croatia 
over the last 15 years. Similar resistance rates were also observed in France and Japan 
(GANIERE et al., 2005; ONUMA et al., 2012) but resistance was lower in North America, 
Norway and Sweden (HOLM et al., 2002; HARTMANN et al., 2005; HARIHARAN et al., 2006; 
NORSTRÖM et al., 2009) which probably refl ects the local policies or recommendations 
for chloramphenicol use.
Resistance to trimethoprim-sulfamethoxazole combination in S. pseudintermedius is 
relatively low. Several studies have reported from 0% to 2.5% resistant strains (HOLM 
et al., 2002; GANIERE et al., 2005; PEDERSEN et al., 2007). However, resistance rates from 
18% to 28% were found among methicillin-sensitive isolates from dogs in Canada and 
the USA (HARTMANN et al., 2005; HARIHARAN et al., 2006) and might be a result of its 
frequent use. In this work, resistance to the trimethoprim-sulfamethoxazole combination 
was found in two out of 98 (2.04%) methicillin-sensitive strains. This proportion is 
understandable considering the relatively low frequency of its use in dogs in Croatia, 
and reveals a potentially useful agent which might not select for resistance to other 
antimicrobials.
In this study, the lowest resistance was observed to enrofl oxacin (5.66%). This is 
higher than found by ŠEOL (2005), where out of 50 isolates of the S. intermedius group 
examined in Croatia, only one was resistant to enrofl oxacin. All isolates resistant to 
enrofl oxacin were multi-resistant MRSP and its emergence probably accounts for the 
rise in resistance to enrofl oxacin in Croatia. In addition, there were two isolates with 
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an intermediate sensitive phenotype, one was MRSP and the other was a multi-resistant 
methicillin-sensitive strain. These results are in agreement with other studies and show 
that resistance to fl uoroquinolones, despite its frequent topical and systemic use in dogs, 
is rare among methicillin-sensitive S. pseudintermedius in Europe and North America 
(HOLM et al., 2002; HARTMANN et al., 2005; HARIHARAN et al., 2006; PEDERSEN et al., 
2007; NORSTRÖM et al., 2009; VANNI et al., 2009; MEUCCI et al., 2010). The high prevalence 
of enrofl oxacin resistance among MRSP is understandable since six out of eight showed 
a multi-resistant pattern typical for the dominant European MRSP clone (PERRETEN et 
al., 2010).
The spread of MRSP exerts pressure for the use of antimicrobials not licensed in 
veterinary medicine and may induce the development of resistance to those antimicrobial 
agents (VAN DUIJKEREN et al., 2010). MRSP has been recognized as an emerging 
zoonotic agent and veterinarians seem to be at higher risk of being colonized (PAUL et 
al., 2011). In order to reduce the selection of methicillin-resistant staphylococci during 
antimicrobial therapy, it would be benefi cial to use agents with a narrow spectrum. In 
addition, appropriate antimicrobial therapy can reduce the length of overall treatment 
and minimize its effect on microbial fl ora. The results of the present study may be used 
for the development of guidelines for empirical therapy of skin and ear infections in dogs 
in Croatia. Antimicrobials that may be appropriate for such treatment are amoxicillin/
clavulanic acid, cephalexin and sulfamethoxazole-trimethoprim. Although the overall 
resistance to enrofl oxacin was low, this antimicrobial should not be used as a fi rst choice 
drug due to its potential for selection of antimicrobial resistance in other bacterial species 
(TROTT et al., 2004). In particular, the effi cacy of fl uoroquinolones should be preserved for 
cases of recurrent or deep pyoderma, and for severe, life-threatening infections associated 
with Gram-negative organisms (GUARDABASSI et al., 2008). Due to the high percentage 
of strains resistant to ampicillin, kanamycin, erythromycin, clindamycin and tetracyclines, 
these drugs should not be used for therapy without prior susceptibility testing. Although 
17.9% and 26.4% of isolates were resistant to gentamicin and chloramphenicol, 
respectively, these agents are mainly used topically (otitis externa and/or conjunctivitis) 
and usually achieve concentrations well above MIC, and may be effective even against 
resistant isolates. Pet owners should be advised to wear gloves when treating animals with 
chloramphenicol. However, use of gentamicin and chloramphenicol in situations with 
documented resistance may lead to prolongation of therapy and should be discouraged 
and replaced by some antistaphylococcal agents, such as fucidic acid or bacitracin. In 
addition, the marked increase in gentamicin resistance rate during the last 15 years in 
Croatia is alarming and might lead to the ineffectiveness of this important antibiotic in 
the future.
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SAŽETAK
Bakterija Staphylococcus pseudintermedius dio je fi ziološke mikrofl ore pasa, ali i čest uzročnik 
oportunističkih zaraza. Kod ove je bakterije primjetan trend porasta rezistencije na antimikrobne lijekove koji 
se učestalo koriste u liječenju pasa. U ovom radu istražena je osjetljivost na antimikrobne lijekove 106 izolata 
bakterije S. pseudintermedius izdvojenih iz pasa i mačaka. Osjetljivost je određena disk-difuzijskim postupkom. 
Izolati su potjecali od bolesnih pasa i mačaka i prikupljeni su u razdoblju od šest mjeseci tijekom godine 2011. 
Većina izolata bila je osjetljiva na amoksicilin s klavulanskom kiselinom, cefaleksin, enrofl oksacin i oksacilin 
(92,5%), sulfametoksazol s trimetoprimom (90,6%) i gentamicin (82,1%). Niži postotak osjetljivosti utvrđen je 
za minociklin (67,0%), eritromicin, klindamicin i tetraciklin (62,3%) te kanamicin (58,5%). Samo 21,7% izolata 
bilo je osjetljivo na ampicilin. U radu je uspoređena učestalost rezistencije između izolata izdvojenih s kože i 
iz zvukovoda, a istražene su i razlike u rezistenciji u odnosu na prijašnje istraživanje provedeno u Hrvatskoj. 
Raspravlja se i o mogućoj povezanosti između rezistencija na različite antimikrobne lijekove.
Ključne riječi: Staphylococcus pseudintermedius, rezistencija, disk-difuzijski postupak ________________________________________________________________________________________
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